Ivermectin; authorize pharmacists to provide to adults under collaborative pharmacy practice agreement.

HB 1722 would have allowed Mississippi pharmacists to provide Ivermectin to adults aged 18+ under a collaborative agreement with healthcare providers, requiring standardized screening tools and patient education materials. Key provisions include mandatory risk assessments, standardized factsheets on proper use and follow-up, and options to dispense or refer patients. The bill also included protections for pharmacists from disciplinary action or lawsuits (unless gross negligence occurred) and permitted administrative fees beyond medication costs. However, the bill died in committee on February 3, 2026, and never became law.